...
search icon
iart-img

Integra LifeSciences Holdings Share Price

IART
NSQ
$11.99
+$0.55
(4.81%)
1D
Industry: Health Care Equipment & Supplies Sector: Health Care

Integra LifeSciences Holdings Analyst Forecast

Integra LifeSciences Holdings Share Price Chart

Integra LifeSciences Holdings Key Stock Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$891.09M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
824.24K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
1.03
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$10.6 L
$25.45 H
$11.99

About Integra LifeSciences Holdings, Common Stock

Integra LifeSciences Holdings Corporation manufactures and sells surgical instrument, neurosurgical, ear, nose, throat, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps and instrumentation, as well as after-market services. It also sells instrument patterns, and surgical and lighting products to hospitals, surgery centers, dental, podiatry, and veterinary offices. In addition, the company addresses the needs of plastic, and reconstructive and general surgeons focused on the treatment of acute wounds, such as burns and chronic wounds, including diabetic foot ulcers; and provides surgical tissue repair products for hernia, tendon, peripheral nerve repair, and protection. Further, it offers skin and wound repair, plastics and surgical reconstruction products, bone grafts, and nerve and tendon repair products. Further, it is involved in the ear, nose, and throat business that includes instrumentation, balloon technologies for sinus dilation and eustachian tube dilation, and surgical navigation systems. The company offers its products directly through various sales forces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, the Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey. more

Industry: Health Care Equipment & SuppliesSector: Health Care

Integra LifeSciences Holdings Stock Returns

Time FrameIARTSectorS&P500
1-Week Return7.25%0.72%-1.31%
1-Month Return-0.17%1.27%0.78%
3-Month Return4.99%3.13%3.46%
6-Month Return-14.66%15.81%6.19%
1-Year Return-48.58%8.89%11.68%
3-Year Return-78.86%20.79%71.21%
5-Year Return-82.58%35.89%74.81%
10-Year Return-58.42%138.44%256.59%

Integra LifeSciences Holdings Financials

Dec '20Dec '21Dec '22Dec '23Dec '245YR TREND
Total Revenue1.37B1.54B1.56B1.54B1.61B[{"date":"2020-12-31","value":85.18,"profit":true},{"date":"2021-12-31","value":95.77,"profit":true},{"date":"2022-12-31","value":96.72,"profit":true},{"date":"2023-12-31","value":95.72,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Cost of Revenue520.83M597.81M587.36M656.84M728.47M[{"date":"2020-12-31","value":71.5,"profit":true},{"date":"2021-12-31","value":82.06,"profit":true},{"date":"2022-12-31","value":80.63,"profit":true},{"date":"2023-12-31","value":90.17,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Gross Profit851.03M944.64M970.31M884.74M882.06M[{"date":"2020-12-31","value":87.71,"profit":true},{"date":"2021-12-31","value":97.35,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":91.18,"profit":true},{"date":"2024-12-31","value":90.9,"profit":true}]
Gross Margin62.03%61.24%62.29%57.39%54.77%[{"date":"2020-12-31","value":99.59,"profit":true},{"date":"2021-12-31","value":98.31,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":92.13,"profit":true},{"date":"2024-12-31","value":87.92,"profit":true}]
Operating Expenses699.66M747.41M731.39M773.21M853.65M[{"date":"2020-12-31","value":81.96,"profit":true},{"date":"2021-12-31","value":87.55,"profit":true},{"date":"2022-12-31","value":85.68,"profit":true},{"date":"2023-12-31","value":90.58,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Operating Income151.37M197.23M238.92M111.53M28.41M[{"date":"2020-12-31","value":63.36,"profit":true},{"date":"2021-12-31","value":82.55,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":46.68,"profit":true},{"date":"2024-12-31","value":11.89,"profit":true}]
Total Non-Operating Income/Expense(120.13M)(26.21M)(62.70M)(64.63M)(97.24M)[{"date":"2020-12-31","value":-12013400000,"profit":false},{"date":"2021-12-31","value":-2621100000,"profit":false},{"date":"2022-12-31","value":-6270300000,"profit":false},{"date":"2023-12-31","value":-6463200000,"profit":false},{"date":"2024-12-31","value":-9724000000,"profit":false}]
Pre-Tax Income93.52M214.68M213.89M81.07M(18.24M)[{"date":"2020-12-31","value":43.56,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":99.64,"profit":true},{"date":"2023-12-31","value":37.76,"profit":true},{"date":"2024-12-31","value":-8.5,"profit":false}]
Income Taxes(40.37M)45.60M33.34M13.33M(11.29M)[{"date":"2020-12-31","value":-88.53,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":73.12,"profit":true},{"date":"2023-12-31","value":29.23,"profit":true},{"date":"2024-12-31","value":-24.76,"profit":false}]
Income After Taxes133.89M169.07M180.55M67.74M(6.94M)[{"date":"2020-12-31","value":74.16,"profit":true},{"date":"2021-12-31","value":93.64,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":37.52,"profit":true},{"date":"2024-12-31","value":-3.85,"profit":false}]
Income From Continuous Operations133.89M169.07M180.55M67.74M(6.94M)[{"date":"2020-12-31","value":74.16,"profit":true},{"date":"2021-12-31","value":93.64,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":37.52,"profit":true},{"date":"2024-12-31","value":-3.85,"profit":false}]
Income From Discontinued Operations-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income133.89M169.07M180.55M67.74M(6.94M)[{"date":"2020-12-31","value":74.16,"profit":true},{"date":"2021-12-31","value":93.64,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":37.52,"profit":true},{"date":"2024-12-31","value":-3.85,"profit":false}]
EPS (Diluted)2.453.183.353.102.56[{"date":"2020-12-31","value":73.13,"profit":true},{"date":"2021-12-31","value":94.93,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":92.54,"profit":true},{"date":"2024-12-31","value":76.42,"profit":true}]

Integra LifeSciences Holdings Ratios

Integra LifeSciences Holdings Liquidity Ratios

These ratios help you determine the liquidity of the company. Higher is better.

IART
Cash Ratio 0.74
Current Ratio 3.14
Quick Ratio 1.80

Integra LifeSciences Holdings Asset Efficiency Ratios

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

IART
ROA (LTM) 2.61%
ROE (LTM) -38.71%

Integra LifeSciences Holdings Liability Ratios

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

IART
Debt Ratio Lower is generally better. Negative is bad. 0.72
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.28

Integra LifeSciences Holdings Valuation Ratios

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

IART
Trailing PE NM
Forward PE 4.89
P/S (TTM) 0.54
P/B 0.86
Price/FCF 35
EV/R 1.60
EV/Ebitda 14.27
PEG 0.71

FAQs

What is Integra LifeSciences Holdings share price today?

Integra LifeSciences Holdings (IART) share price today is $11.99

Can Indians buy Integra LifeSciences Holdings shares?

Yes, Indians can buy shares of Integra LifeSciences Holdings (IART) on Vested. To buy

from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in IART stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Integra LifeSciences Holdings be purchased?

Yes, you can purchase fractional shares of Integra LifeSciences Holdings (IART) via the Vested app. You can start investing in Integra LifeSciences Holdings (IART) with a minimum investment of $1.

How to invest in Integra LifeSciences Holdings shares from India?

You can invest in shares of Integra LifeSciences Holdings (IART) via Vested in three simple steps:

  • Click on Sign Up or Invest in IART stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Integra LifeSciences Holdings shares
What is Integra LifeSciences Holdings 52-week high and low stock price?

The 52-week high price of Integra LifeSciences Holdings (IART) is $25.45. The 52-week low price of Integra LifeSciences Holdings (IART) is $10.6.

What is Integra LifeSciences Holdings price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Integra LifeSciences Holdings (IART) is

What is Integra LifeSciences Holdings price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Integra LifeSciences Holdings (IART) is 0.86

What is Integra LifeSciences Holdings dividend yield?

The dividend yield of Integra LifeSciences Holdings (IART) is 0.00%

What is the Market Cap of Integra LifeSciences Holdings?

The market capitalization of Integra LifeSciences Holdings (IART) is $891.09M

What is Integra LifeSciences Holdings's stock symbol?

The stock symbol (or ticker) of Integra LifeSciences Holdings is IART

How Can Investors Use Integra LifeSciences Holdings Share Price Data for Long-Term Investment Decisions?

Consider the share price of Integra LifeSciences Holdings as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether Integra LifeSciences Holdings has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.

How does USD - INR currency movement impact returns from Integra LifeSciences Holdings shares for Indian investors?

When investing in Integra LifeSciences Holdings shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the Integra LifeSciences Holdings stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.

How should investors compare Integra LifeSciences Holdings share price with other stocks in the same sector?

Rather than merely checking the share price of Integra LifeSciences Holdings and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that Integra LifeSciences Holdings stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top